Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,405.00    -50.00 (-0.92%)
Bid:
5,395.00
Ask:
5,405.00
Spread: 10.00 (0.185%)
Market Cap: £3.93b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Form 8.3 - Renishaw PLC

7 Jun 2021 11:24

RNS Number : 0438B
Baillie Gifford & Co.
07 June 2021
Β 

FORMΒ 8.3

Β 

PUBLICΒ OPENINGΒ POSITIONΒ DISCLOSURE/DEALINGΒ DISCLOSUREΒ BY

AΒ PERSONΒ WITHΒ INTERESTSΒ INΒ RELEVANTΒ SECURITIESΒ REPRESENTINGΒ 1%Β OR MORE

RuleΒ 8.3Β ofΒ theΒ TakeoverΒ CodeΒ (theΒ "Code")

Β 

1. KEYΒ INFORMATION

Β 

(a) Full name of discloser:

Baillie Gifford & Co

(b) Owner or controller of interests and short

positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Β 

(c) Name of offeror/offeree in relation to whose

relevant securities this form relates:

Use a separate form for each offeror/offeree

Renishaw Plc

(d) If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of offeror/offeree:

Β 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

04 June 2021

(f) In addition to the company in 1(c) above, is the

discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

Β 

Β 

2. POSITIONSΒ OFΒ THEΒ PERSONΒ MAKINGΒ THEΒ DISCLOSURE

Β 

IfΒ thereΒ areΒ positionsΒ orΒ rightsΒ toΒ subscribeΒ toΒ discloseΒ inΒ moreΒ thanΒ oneΒ classΒ ofΒ relevant securitiesΒ ofΒ theΒ offerorΒ orΒ offereeΒ namedΒ in 1(c),Β copyΒ tableΒ 2(a)Β orΒ (b)Β (as appropriate)Β for eachΒ additionalΒ classΒ of relevantΒ security.

Β 

(a) InterestsΒ andΒ shortΒ positionsΒ inΒ theΒ relevantΒ securitiesΒ ofΒ theΒ offerorΒ orΒ offeree toΒ whichΒ theΒ disclosureΒ relatesΒ followingΒ theΒ dealingΒ (ifΒ any)

Β 

Class of relevant security:

20p Ordinary

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned

and/or controlled:

4,918,534

6.76

Β 

Β 

(2) Cash-settled derivatives:

Β 

Β 

Β 

Β 

(3) Stock-settled derivatives

(including options) and agreements to purchase/sell:

Β 

Β 

Β 

Β 

Β 

TOTAL:

4,918,534

6.76

Β 

Β 

Β 

AllΒ interestsΒ andΒ allΒ shortΒ positionsΒ shouldΒ be disclosed.

Β 

Details Β of Β any Β open Β stock-settled Β derivative Β positions Β (including Β traded Β options), Β or agreementsΒ toΒ purchaseΒ orΒ sellΒ relevantΒ securities,Β shouldΒ beΒ givenΒ onΒ aΒ Supplemental FormΒ 8Β (OpenΒ Positions).

(b) RightsΒ toΒ subscribeΒ forΒ newΒ securitiesΒ (includingΒ directors'Β andΒ otherΒ employee options)

Β 

Class of relevant security in relation to

which subscription right exists:

Β 

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

Β 

3. Β DEALINGSΒ (IFΒ ANY)Β BYΒ THEΒ PERSONΒ MAKINGΒ THEΒ DISCLOSURE

Β 

WhereΒ thereΒ have beenΒ dealingsΒ in moreΒ than oneΒ classΒ of relevantΒ securitiesΒ of theΒ offerorΒ or offeree named inΒ 1(c), copyΒ table 3(a), (b), (c)Β orΒ (d)Β (asΒ appropriate)Β forΒ each additionalΒ class ofΒ relevantΒ securityΒ dealtΒ in.

Β 

TheΒ currencyΒ ofΒ allΒ pricesΒ andΒ otherΒ monetaryΒ amountsΒ shouldΒ beΒ stated.

Β 

(a) Β PurchasesΒ andΒ sales

Β 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

20p Ordinary

Sale

12,453

55.109

Β 

(b) Cash-settledΒ derivativeΒ transactions

Β 

Class of

relevant security

Product

description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of

reference securities

Price per

unit

Β 

Β 

Β 

Β 

Β 

Β 

(c) Stock-settledΒ derivativeΒ transactionsΒ (includingΒ options)

Β 

(i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Class

of relevant security

Product

description e.g. call option

Writing,

purchasing, selling, varying etc.

Number

of securities to which option relates

Exercise

price per unit

Type

e.g. American, European etc.

Expiry

date

Option

money paid/ received per unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii) Exercise

Β 

Class of

relevant security

Product

description

e.g. call option

Exercising/

exercised against

Number of

securities

Exercise price

per unit

Β 

Β 

Β 

Β 

Β 

(d) OtherΒ dealingsΒ (includingΒ subscribingΒ forΒ newΒ securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

Β 

Β 

4. OTHERΒ INFORMATION

Β 

(a) IndemnityΒ andΒ otherΒ dealingΒ arrangements

Β 

DetailsΒ ofΒ anyΒ indemnityΒ orΒ optionΒ arrangement,Β orΒ anyΒ agreementΒ orΒ understanding, formalΒ orΒ informal,Β relatingΒ toΒ relevantΒ securitiesΒ whichΒ mayΒ beΒ anΒ inducementΒ toΒ deal orΒ refrainΒ fromΒ dealingΒ enteredΒ intoΒ byΒ theΒ personΒ makingΒ theΒ disclosureΒ andΒ anyΒ party toΒ theΒ offerΒ orΒ anyΒ personΒ actingΒ inΒ concertΒ withΒ aΒ partyΒ toΒ theΒ offer:

IrrevocableΒ commitmentsΒ andΒ lettersΒ of intentΒ shouldΒ notΒ be included.Β IfΒ thereΒ areΒ noΒ such agreements,Β arrangementsΒ orΒ understandings,Β stateΒ "none"

Β 

None

Β 

Β 

Β 

(b) Agreements,Β arrangementsΒ orΒ understandingsΒ relatingΒ toΒ optionsΒ orΒ derivatives

Β 

DetailsΒ ofΒ anyΒ agreement,Β arrangementΒ orΒ understanding,Β formalΒ orΒ informal,Β between theΒ personΒ makingΒ theΒ disclosureΒ andΒ anyΒ otherΒ personΒ relatingΒ to:

(i)Β theΒ votingΒ rightsΒ ofΒ anyΒ relevantΒ securitiesΒ underΒ anyΒ option;Β or

(ii)Β theΒ votingΒ rightsΒ orΒ futureΒ acquisitionΒ orΒ disposalΒ ofΒ anyΒ relevantΒ securitiesΒ toΒ which anyΒ derivativeΒ isΒ referenced:

IfΒ thereΒ areΒ noΒ suchΒ agreements,Β arrangementsΒ orΒ understandings,Β stateΒ "none"

Β 

Β 

None

Β 

Β 

(c) Attachments

Β 

IsΒ aΒ SupplementalΒ FormΒ 8 (OpenΒ Positions)Β attached? NO

Β 

Β 

Β 

Date of disclosure:

07.06.2021

Contact name:

Alan Gilliland-Patterson

Telephone number:

0131 275 3779

Β 

PublicΒ disclosuresΒ underΒ RuleΒ 8Β ofΒ theΒ CodeΒ mustΒ beΒ madeΒ toΒ aΒ RegulatoryΒ Information

Service.

Β 

TheΒ Panel'sΒ MarketΒ SurveillanceΒ UnitΒ isΒ availableΒ forΒ consultationΒ inΒ relationΒ toΒ theΒ Code's disclosureΒ requirementsΒ on +44Β (0)20Β 7638Β 0129.

Β 

TheΒ CodeΒ canΒ be viewedΒ onΒ the Panel'sΒ websiteΒ atΒ Β www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETSSSFSWEFSEEM
Date   Source Headline
6th May 20267:00 amRNSTrading Statement
20th Apr 20267:00 amRNSTrading Statement
8th Apr 20267:00 amRNSBoard Changes
11th Feb 20267:00 amRNSHalf-year Financial Report
29th Jan 202612:00 pmRNSNotice of Half-year Results
28th Nov 202511:00 amRNSHolding(s) in Company
28th Nov 202511:00 amRNSHolding(s) in Company
27th Nov 20256:29 pmRNSHolding(s) in Company
27th Nov 20255:00 pmRNSDirector/PDMR Shareholding
26th Nov 20251:32 pmRNSResult of AGM
26th Nov 20258:30 amRNSShareholdings update
29th Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSTrading Statement
21st Oct 20253:02 pmRNSVoting Arrangement
21st Oct 20253:00 pmRNSHolding(s) in Company
21st Oct 20253:00 pmRNSHolding(s) in Company
3rd Oct 20257:00 amRNSAnnual Financial Report
24th Sep 20257:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSNew reporting segments for FY2026
18th Sep 20257:00 amRNSFinal Results
21st Aug 20257:00 amRNSBoard Change and Trading Update
13th Aug 20257:00 amRNSDirectorate Change
17th Jun 20257:00 amRNSCapital Markets Day
8th May 20257:00 amRNSTrading Statement
14th Apr 20259:49 amRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSHalf-year Report
9th Dec 20242:02 pmRNSDeath of Sir David McMurtry
27th Nov 20242:44 pmRNSResult of AGM
29th Oct 20241:28 pmRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSTrading Statement
27th Sep 20247:15 amRNSAnnual Financial Report
12th Sep 20247:00 amRNSFinal Results
29th Aug 20242:00 pmRNSNotice of Results
1st Jul 20247:00 amRNSDirectorate Change
13th Jun 20247:00 amRNSDirectorate Change
16th May 20242:25 pmRNSAGM Voting Results Update Statement
8th May 20247:00 amRNSTrading Statement
2nd Apr 20245:19 pmRNSStatement regarding Renishaw plc
6th Feb 20247:00 amRNSHalf-year Report
30th Jan 202410:30 amRNSChange of Adviser
23rd Jan 20249:00 amRNSNotice of Half-year Results
29th Nov 20232:47 pmRNSResult of AGM
26th Oct 20237:00 amRNSTrading Statement
13th Oct 20237:00 amRNSNotice of AGM
3rd Oct 20237:00 amRNSAnnual Financial Report
19th Sep 20237:00 amRNSFinal Results
13th Sep 20237:00 amRNSRevised date for publication of results
21st Aug 20233:00 pmRNSDirectorate Change
12th Jul 20232:30 pmRNSVoting Arrangement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.